Skandinaviska Enskilda Banken (SEB)
IMUX icon

Skandinaviska Enskilda Banken (SEB)’s Immunic IMUX Stock Holding History

Skandinaviska Enskilda Banken (SEB)’s Portfolio IMUX Stock Details IMUX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3,616
Closed -$320K – 1035
2021
Q3 		$320K Sell
3,616
-955
-21% -$94K ﹤0.01% 896
2021
Q2 		$560K Hold
4,571
– – ﹤0.01% 872
2021
Q1 		$729K Buy
+4,571
New +$775K ﹤0.01% 879

Other funds holding IMUX

OFM
Omega Fund Management Boston, Massachusetts $163M AUM 107.06% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
SFM
Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB)'s IMUX Position: Q4 2021 in Review

Skandinaviska Enskilda Banken (SEB) sold out of Immunic (IMUX) in Q4 2021, closing a stake of 3,616 shares — an estimated $320K sold.

Skandinaviska Enskilda Banken (SEB) first reported a position in IMUX in Q1 2021 and held it in 3 quarters. The position peaked at $729K in Q1 2021. 67 funds tracked by Wall St. Rank hold IMUX as of Q4 2021.

  • Skandinaviska Enskilda Banken (SEB) reported no remaining Immunic position as of Q4 2021 after selling out during the quarter.
  • Skandinaviska Enskilda Banken (SEB) sold 3,616 Immunic shares in Q4 2021, an estimated $320K.
  • Skandinaviska Enskilda Banken (SEB) first reported a position in Immunic in Q1 2021 and held it in 3 quarters.
  • Skandinaviska Enskilda Banken (SEB)'s Immunic position peaked at $729K in Q1 2021.
  • 67 funds tracked by Wall St. Rank held Immunic as of Q4 2021.

Based on Skandinaviska Enskilda Banken (SEB)'s 13F filing for Q4 2021, filed 10 Feb 2022.